Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

Journal of Clinical Lipidology

Volumn 5, Issue 2, 2011, Pages 105-113

  Otvos, James D ^a   Mora, Samia ^b   Shalaurova, Irina ^a   Greenland, Philip ^c   MacKey, Rachel H ^d   Goff Jr , David C ^e  

^a LIPOSCIENCE INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease risk; LDL cholesterol; LDL particle number; Lipoproteins; NMR

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN PARTICLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 79952515201     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.02.001     Document Type: Article

References (29)

1. J.D. Otvos, E.J. Jeyarajah, and W.C. Cromwell Measurement issues related to lipoprotein heterogeneity Am J Cardiol 90 suppl 2002 22i 29i (Pubitemid 35284908)
2. W.C. Cromwell, J.D. Otvos, and M.J. Keyes LDL particle number and risk for future cardiovascular disease in the Framingham Offspring Study - implications for LDL management J Clin Lipidol 1 2007 583 592 (Pubitemid 350215511)
3. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844 (Pubitemid 350287108)
4. J.D. Brunzell, M. Davidson, and C.D. Furberg Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524 (Pubitemid 351470037)
5. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870 (Pubitemid 44716510)
6. R.S. Rosenson, J.D. Otvos, and D.S. Freedman Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) Trial Am J Cardiol 90 2002 89 94 (Pubitemid 34775113)
7. S. Mora, M. Szklo, and J.D. Otvos LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis Atherosclerosis 192 2007 211 217 (Pubitemid 46602300)
8. L.H. Kuller, A. Arnold, and R. Tracy Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study Arterioscler Thromb Vasc Biol 22 2002 1175 1180 (Pubitemid 34764870)
9. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, and P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 937
10. J.D. Otvos, D. Collins, and D.S. Freedman LDL and HDL particle subclasses predict coronary events and are changed favorably by gemfibrozil therapy in the Veterans Affairs HDL Intervention Trial (VA-HIT) Circulation 113 2006 1556 1563 (Pubitemid 43739414)
11. K. El Harchaoui, W.A. van der Steeg, and E.S. Stroes Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 49 2007 547 553 (Pubitemid 46177441)
12. P. Glasziou, L. Irwig, and J.J. Deeks When should a new test become the current reference standard? Ann Intern Med 149 2008 816 821
13. D.E. Bild, D.A. Bluemke, and G.L. Burke Multi-Ethnic Study of Atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881 (Pubitemid 35215769)
14. A.R. Folsom, R.A. Kronmal, and R.C. Detrano Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence Arch Intern Med 168 2008 1333 1339 (Pubitemid 351930841)
15. D.H. O'Leary, J.F. Polak, and R.A. Kronmal Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group Stroke 27 1996 224 231
16. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
17. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
18. A.D. Sniderman Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice J Clin Lipidol 2 2008 36 42 (Pubitemid 351250867)
19. A.D. Sniderman, A.C. St-Pierre, B. Cantin, G.R. Dagenais, J.-P. Despres, and B. Lamarche Concordance/discordance between plasma apolipoprotein B levels and cholesterol indexes of atherosclerotic risk Am J Cardiol 91 2003 1173 1177 (Pubitemid 36561379)
20. K.K. Berneis, and R.M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J Lipid Res 43 2002 1363 1379
21. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report Circulation 106 2002 3143 3421
22. S. Kathiresan, J.D. Otvos, and L.M. Sullivan Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study Circulation 113 2006 20 29 (Pubitemid 43958484)
23. R.S. Rosenson, J.D. Otvos, and J. Hsia Effects of rosuvastatin and atorvastatin on low-density and high-density lipoprotein particle concentrations in patients with the metabolic syndrome: a randomized, double-blind, controlled study Diabetes Care 32 2009 1087 1091
24. W.C. Cromwell, and J.D. Otvos Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dL Am J Cardiol 98 2006 1599 1602 (Pubitemid 44827965)
25. P. Deedwania, P. Barter, and R. Carmena Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study Lancet 368 2006 919 928 (Pubitemid 44331360)
26. J. Hsia, J.D. Otvos, and J.E. Rossouw Lipoprotein particle concentrations may explain the absence of coronary protection in the Women's Health Initiative hormone trials Arterioscler Thromb Vasc Biol 28 2008 1666 1671
27. J.T. Kuvin, D.M. Dave, and K.A. Sliney Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease Am J Cardiol 98 2006 743 745 (Pubitemid 44301006)
28. R.B. Goldberg, D.M. Kendall, and M.A. Deeg A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with Type 2 diabetes and dyslipidemia Diabetes Care 18 2005 1547 1554 (Pubitemid 40923063)
29. W.E. Kraus, J.A. Houmard, and B.D. Duscha Effects of the amount and intensity of exercise training on plasma lipoproteins N Engl J Med 347 2002 1483 1492 (Pubitemid 35257587)